The Official Journal of the Turkish Society Of Clinical Microbiology and Infectious Diseases (KLİMİK)

Original Article

Filter Newest Oldest Showing 1-20 of 155 results
Original Article / VOLUME 7, ISSUE 3, SEPTEMBER 2025

Measles: The Re-emergence of a Vaccine-Preventable Disease

Ahmet Şahin and others

Measles is a highly contagious, airborne, acute febrile disease caused by an enveloped, single-stranded RNA virus belonging to the Morbillivirus genus of the Paramyxoviridae family. It typically presents [...] Read More

Original Article / VOLUME 7, ISSUE 3, SEPTEMBER 2025

Monitoring of Patients Receiving Immunosuppressive and Biological Agent Treatments for Infectious Complications

Ayşe Gülden Bekgöz and others

Immunosuppressive drugs are increasingly used in the treatment of rheumatologic diseases to achieve disease remission, reduce the frequency of attacks, and prevent relapses. Since the late 1990s, advancements in molecular biology, immunology, and pharmaceutical technologies have led to various new treatment approaches for autoimmune-associated inflammatory diseases. Read More

Original Article / VOLUME 7, ISSUE 3, SEPTEMBER 2025

Antimicrobial Use at a Tertiary-Care Hospital in Türkiye According to the WHO Access, Watch and Reserve (AWaRe) Classification: A Point Prevalence Survey

Muammer Çelik and others

Healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) represent major threats to global health. The global increase in AMR is primarily attributed to unnecessary or inappropriate use of antibiotics in humans and animals. Antibiotics, unlike other drugs, are a valuable resource that requires [...] Read More

Original Article / VOLUME 7, ISSUE 3, SEPTEMBER 2025

Impact of the COVID-19 Pandemic on CLABSI Rates and Antibiotic Resistance: A Multicenter Study in Türkiye

Elif Sargın-Altunok and others

Healthcare-associated infections (HAIs) are common yet largely preventable through adherence to evidence-based guidelines. In 2005, Türkiye implemented a national infection control program, which led to significant reductions in HAI rates, including a 50% decrease in central line-associated bloodstream infections (CLABSIs) between 2008 and 2017. This result was in parallel with data from [...] Read More

Original Article / VOLUME 7, ISSUE 3, SEPTEMBER 2025

Clinical Features, Treatment Interventions, and Oral Health-Related Quality of Life in Patients with COVID-19-Associated Mucormycosis: A Descriptive-Analytical Study

Sana Baghban and others

The COVID-19 pandemic has had a profound negative impact on global human health, due to both direct harmful effects of the SARS-CoV-2 virus and the associated superinfections. Notably, two mold infections—aspergillosis and mucormycosis—have been observed in affected patients. Read More

Original Article / VOLUME 7, ISSUE 3, SEPTEMBER 2025

Comprehensive Molecular Epidemiology of HPV in a High-Volume Tertiary Center

İsmail Selçuk Aygar and Mehmet Tevfik Yavuz

Human papillomavirus (HPV) is a non-enveloped, double-stranded DNA virus that infects humans exclusively. It is classified within the Papillomaviridae family and replicates in skin and mucosal epithelial cells. Human papillomavirus is regarded as one of the most prevalent sexually transmitted viral infections, having the capacity [...] Read More

Original Article / VOLUME 7, ISSUE 3, SEPTEMBER 2025

Analyzing Turkish-Language HPV Vaccination Videos on YouTube: Assessing Content Quality and Educational Value

Elif Özeller and others

Cervical cancer is the fourth most common cancer among women worldwide. Epidemiologically and molecularly, the human papillomavirus (HPV) is a circular, double-stranded DNA virus known to cause chronic infections and is the primary cause of cervical cancer. Other cancers associated with HPV include vulvar[...] Read More

Original Article / VOLUME 7, ISSUE 2, JUNE 2025

Characteristics and Distribution of Fungal Meningitis: A Systematic Review

Armina Khalilzadegan and others

In recent decades, fungal infections of the central nervous system (CNS) have increased significantly. Of more than 100,000 identified fungal species, approximately 10 to 15% are responsible for implicated fungal-related neurological diseases. A significant clinical manifestation of fungal infections of the CNS is meningitis, a serious condition marked [...] Read More

Original Article / VOLUME 7, ISSUE 2, JUNE 2025

The Definition, Prevalence, and Risk Factors of Augmented Renal Clearance in Adult Patients on Antimicrobial Therapy: A Scoping Review

Hasan Memiş and others

Antibiotic resistance has become a significant public health concern, primarily due to irrational antibiotic use. Healthcare and antimicrobial stewardship depend on using antibiotics correctly for several reasons. In the first place, adhering to the prescribed dosage ensures that the body receives the right amount of antibiotics to treat [...] Read More

Original Article / VOLUME 7, ISSUE 2, JUNE 2025

The Role of Serial Monitoring of Laboratory Parameters in Determining the Need for Intensive Care in Severe COVID-19: A Single-Center Retrospective Study

Elif Nur Özbay-Haliloğlu and Zeynep Tekin-Taş

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to significant hospitalizations and mortality globally from 2019 to 2021. According to data from the World Health Organization (WHO), over 776 million COVID-19 cases and more than 7 million COVID-19-related deaths have been reported to date. Although [...] Read More

Original Article / VOLUME 7, ISSUE 2, JUNE 2025

Prognostic Factors in COVID-19 Patients with Ventilator-Associated Pneumonia: A Single-Centre Experience

Hilal Ekici and others

Coronavirus disease 2019 (COVID-19) is a disease with a wide clinical spectrum ranging from mild to moderate illness to acute respiratory distress syndrome (ARDS) and death. Approximately 25% of patients with COVID-19-related ARDS required mechanical ventilation due to respiratory failure and were treated in intensive [...] Read More

Original Article / VOLUME 7, ISSUE 2, JUNE 2025

Quantitative Immunoglobulin G and Interferon-Gamma Responses After Different Booster Strategies of CoronaVac and BNT162b2 Vaccines in Türkiye

Aylin İrem Ocaklı and others

The straightforward way to keep the course of the pandemic under control is herd immunity, which is established with a vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). There is a need to develop appropriate laboratory tools to predict the efficacy of vaccines and evaluate the post-vaccination immune response. Read More

Original Article / VOLUME 7, ISSUE 2, JUNE 2025

Detection of Hypervirulent ST-17 Clone Among Clinical Group B Streptococcus Isolates Using MALDI-TOF MS and PCR

Gülşah Malkoçoğlu and others

Group B Streptococcus (GBS), Streptococcus agalactiae, is generally found as a colonizer of the genital and gastrointestinal tracts, and vertical transmission from colonized mothers to newborns during childbirth can result in serious infections. This bacterium is a leading cause of sepsis and meningitis in neonates and is also associated with several invasive and non-invasive [...] Read More

Original Article / VOLUME 7, ISSUE 2, JUNE 2025

Risk Factors for Cytomegalovirus Reactivation and Its Impact on Clinical Outcomes in Immunocompetent Seropositive Patients Admitted to the Intensive Care Unit: A Single-Center Prospective Observational Study

Hacer Ceylan Çimendağ and others

Cytomegalovirus (CMV) is a DNA belonging to the family Herpesviridae and subfamily Betaherpesvirinae. CMV seropositivity rate in Turkiye varies between 85% and 100% . Following primary infection, CMV remains latent for life in myeloid cells, such as monocytes, macrophages, and dendritic cells. It can reactivate when [...] Read More

Original Article / VOLUME 7, ISSUE 2, JUNE 2025

Potential Predictors of the Outcome of Tocilizumab Treatment in Patients with COVID-19-Associated Hyperinflammation

Shirkhan Amikishiyev and others

Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, typically presents with mild to moderate course in the majority of infected individuals. During the pandemic, nearly 30% of patients required hospitalization, and a subset developed a severe disease characterized by respiratory failure and needed intensive care support. Read More

Original Article / VOLUME 7, ISSUE 2, JUNE 2025

Development of a Liquid Chromatography-Tandem Mass Spectrometry Method for Quantifying Teicoplanin and Its Application in Critically Ill Patients

Hasan Memiş and others

Healthcare-associated infections are frequently encountered in intensive care units (ICUs), with more than 30% of all ICU admissions having an infection. For decades, antibiotics have provided an effective treatment for infectious diseases. Since most antibiotic resistance is caused by misuse or abuse of antibiotics, one of the strategies that could [...] Read More

Original Article / VOLUME 7, ISSUE 1, MARCH 2025

Healthcare-Associated Infection Rates in Türkiye (2014-2023): A Systematic Review and Meta-Analysis

Bahar Madran and others

Healthcare-associated infections (HAIs) are accepted as one of the most important challenges in hospital settings. They cause extended lengths of stay -at the hospital, threatening patient safety, increasing the rate of morbidity and mortality, raising the workforce of healthcare workers and accelerating antimicrobial resistance. According to the World Health Organization (WHO), [...] Read More

Original Article / VOLUME 7, ISSUE 1, MARCH 2025

Determination of the Viremia and Genotype Distribution of the Hepatitis C Virus and the Seroprevalence of HIV Co-Infection

Fatih Mehmet Akıllı and others

Hepatitis C virus (HCV) is an enveloped, single-stranded, positive polarity RNA virus from the Flaviviridae family. It is part of the Hepacivirus genus, wrapped in a lipid bilayer containing two viral glycoproteins (E1 and E2). HCV infection is a major public health problem that can lead to complications such as cirrhosis and liver cancer. Approximately 85% of people [...] Read More